This Article Full Text Full Text (PDF) All Versions of this Article: 97/1/16    most recent 01.RES.0000172568.49367.f8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Casanello, P. Articles by Sobrevia, L. Search for Related Content PubMed PubMed Citation Articles by Casanello, P. Articles by Sobrevia, L. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Other diabetes Glucose intolerance Endothelium/vascular type/nitric oxide Other Vascular biology Other Research Related Article

(Circulation Research. 2005;97:16.)
© 2005 American Heart Association, Inc.

Molecular Medicine

Equilibrative Nucleoside Transporter 1 Expression Is Downregulated by Hypoxia in Human Umbilical Vein Endothelium

Paola Casanello, Alberto Torres, Felipe Sanhueza, Marcelo González, Marcelo Farías, Victoria Gallardo, Marçal Pastor-Anglada, Rody San Martín, Luis Sobrevia

From the Cellular and Molecular Physiology Laboratory (CMPL) (P.C., A.T., F.S., M.G., M.F., V.G., R.S.M., L.S.), Department of Obstetrics and Gynaecology, Medical Research Centre (CIM), School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago; Universidad de Concepción (V.G.), Chile; and the Departament de Bioquímica i Biologia Molecular (M.P.-A.), Universitat de Barcelona, Spain.

Correspondence to Dr Luis Sobrevia, Cellular and Molecular Physiology Laboratory (CMPL), Department of Obstetrics and Gynaecology, Medical Research Centre (CIM), School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, P.O. Box 114-D, Santiago, Chile. E-mail sobrevia{at}med.puc.cl

Reduced oxygen level (hypoxia) induces endothelial dysfunction and release of the endogenous nucleoside adenosine. Human umbilical vein endothelium (HUVEC) function in an environment with 3% to 5% O₂ and exhibit efficient adenosine membrane transport via human equilibrative nucleoside transporters 1 (hENT1). We studied whether adenosine transport and hENT1 expression are altered by hypoxia in HUVEC. Hypoxia (0 to 24 hours, 2% and 1% O₂) reduced maximal hENT1-adenosine transport velocity (V_max) and maximal nitrobenzylthionosine (NBMPR, a high-affinity hENT1 protein ligand) binding, but increased extracellular adenosine concentration. Hypoxia also reduced hENT1 protein and mRNA levels, effects unaltered by N-nitro-L-arginine methyl ester (L-NAME, nitric oxide synthase [NOS] inhibitor) or PD-98059 (inhibitor of mitogen-activated protein kinase kinase 1 and 2 [MEK1/2]). Hypoxia reduced endothelial NOS (eNOS) activity and eNOS phosphorylation at Ser¹¹⁷⁷, but increased eNOS protein level. Hypoxia increased (1 to 3 hours), but reduced (24 hours) p42/44^mapk phosphorylation. Thus, hypoxia-increased extracellular adenosine may result from reduced hENT1-adenosine transport in HUVEC. Hypoxia effect seems not to involve NO, but p42/44^mapk may be required for the relatively rapid effect (1 to 3 hours) of hypoxia. These results could be important in diseases where the fetus is exposed to intrauterine environments poor in oxygen, such as intrauterine growth restriction, or where adenosine transport is altered, such as gestational diabetes.

Key Words: endothelium • hypoxia • adenosine

Related Article:

Control of Adenosine Transport by Hypoxia

Agnes Görlach
Circ. Res. 2005 97: 1-3. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				J. L. Vega, C. Puebla, R. Vasquez, M. Farias, J. Alarcon, M. Pastor-Anglada, B. Krause, P. Casanello, and L. Sobrevia TGF-{beta}1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium Cardiovasc Res, June 1, 2009; 82(3): 458 - 467. [Abstract] [Full Text] [PDF]

				M. D. Seferovic, R. Ali, H. Kamei, S. Liu, J. M. Khosravi, S. Nazarian, V. K. M. Han, C. Duan, and M. B. Gupta Hypoxia and Leucine Deprivation Induce Human Insulin-Like Growth Factor Binding Protein-1 Hyperphosphorylation and Increase Its Biological Activity Endocrinology, January 1, 2009; 150(1): 220 - 231. [Abstract] [Full Text] [PDF]

				W. Lam, C.-H. Leung, S. Bussom, and Y.-C. Cheng The Impact of Hypoxic Treatment on the Expression of Phosphoglycerate Kinase and the Cytotoxicity of Troxacitabine and Gemcitabine Mol. Pharmacol., September 1, 2007; 72(3): 536 - 544. [Abstract] [Full Text] [PDF]

				M. Loffler, J. C. Morote-Garcia, S. A. Eltzschig, I. R. Coe, and H. K. Eltzschig Physiological Roles of Vascular Nucleoside Transporters Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1004 - 1013. [Abstract] [Full Text] [PDF]

				F. C Luft Achieving the goal of optimised renin system suppression: preclinical experience with a direct renin inhibitor Journal of Renin-Angiotensin-Aldosterone System, June 1, 2006; 7(2_suppl): S12 - S15. [Abstract] [PDF]

				A. Gorlach Control of Adenosine Transport by Hypoxia Circ. Res., July 8, 2005; 97(1): 1 - 3. [Full Text] [PDF]